# Revolution Medicines, Inc.: Form 8-K, filed Oct 13, 2026

- Company: [Revolution Medicines, Inc.](/companies/rvmd.md) (CIK 1628171)
- Form: 8-K
- Filed: 2026-10-13
- Accepted by EDGAR: Oct 13, 2026, 16:32 ET
- Period: 2026-10-08
- Accession: 0001628171-26-000004
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1628171/000162817126000004/rvmd-20261008.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1628171/000162817126000004/

## Items reported

- Item 2.03: New direct financial obligation
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1628171/000162817126000004/rvmd-20261008.htm

Filed Oct 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001628171-26-000004. Last ingested by Listed: Nov 5, 2026, 14:01 ET. No prices; not investment advice.